Effects of Xuezhikang Capsule (血脂康胶囊) on High Risk Population in Chinese Coronary Secondary Prevention Study (CCSPS) and the Enlightenment from It
Effects of Xuezhikang Capsule (血脂康胶囊) on High Risk Population in Chinese Coronary Secondary Prevention Study (CCSPS) and the Enlightenment from It作者机构：Fuwai Hospital of Cardiovascular Diseases Chinese Academy of Medical Sciences Beijing (100037)
出 版 物：《Chinese Journal of Integrated Traditional and Western Medicine》 (中国中西医结合杂志（英文版）)
年 卷 期：2006年第12卷第2期
页 面：87-89页
学科分类：100506[医学-中医内科学] 1006[医学-中西医结合] 1005[医学-中医学] 10[医学] 100602[医学-中西医结合临床]
主 题：Xuezhikang Capsule 血脂康胶囊 clinical trial
摘 要：Summery of CCSPS Trial and Its Sub-group Analysis Chinese coronary secondary prevention study （CCSPS）, one of the key items of the Ninth Five-year Plan of China, is a largescale multicenter, randomized, double-blinded and placebo controlled clinical trial. From May 1996 to Dec. 2003, 4 870 patients with definite history of myocardial infarction, aged 18- 75 years with their serum cholesterol levels ranging 4.40- 6.47 mmol/L （ 170- 250 mg/dl）,
维普期刊数据库
同方期刊数据库